Moneycontrol PRO
HomeNewsNavneeteducation

Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

Jump to
  • Wealth creators: Long term investors could buy these 3 pharma stocks

    Investors need to be careful while selecting stocks in midcap space as any unfavourable result in state elections would result in a drastic fall in midcaps and smallcaps

  • 4 strong quality contrarian buys post the recent correction

    4 strong quality contrarian buys post the recent correction

    The escalating load of NPAs, bond yields and decline in credit growth rate are major issues faced by state run banks.

  • Market awaits corporate earnings, macro data; top 10 stocks which can give up to 49% return

    Market awaits corporate earnings, macro data; top 10 stocks which can give up to 49% return

    Now all eyes are on corporate earnings and Karnataka elections along with crude oil movement, experts suggest.

  • Sell REC, Bank of India, Asian Paints, HDFC Bank; buy Tech Mahindra, Natco Pharma: Ashwani Gujral

    Sell REC, Bank of India, Asian Paints, HDFC Bank; buy Tech Mahindra, Natco Pharma: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com is of the view that one can sell REC, Bank of India, Asian Paints and HDFC Bank and can buy Tech Mahindra and Natco Pharma.

  • Buy Ashok Leyland, NMDC, JSW Steel: Ashwani Gujral

    Buy Ashok Leyland, NMDC, JSW Steel: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com is of the view that one can buy Ashok Leyland, NMDC and JSW Steel.

  • Prefer Natco Pharma, says Gaurang Shah

    Prefer Natco Pharma, says Gaurang Shah

    Gaurang Shah of Geojit Financial Services is of the view that one may prefer Natco Pharma.

  • Bull's Eye: Buy Natco Pharma, DCM Shriram, Rain Industries, GHCL, Camlin Fine, Jamna Auto

    Bull's Eye: Buy Natco Pharma, DCM Shriram, Rain Industries, GHCL, Camlin Fine, Jamna Auto

    Ruchit Jain of Angel Broking recommends buying Natco Pharma with a stoploss at Rs 995 and target of Rs 1080 and a buy on GHCL with a stoploss at Rs 286 and target of Rs 327.

  • Buy HDFC Bank, Natco Pharma, Hindalco Industries, Axis Bank; sell TCS: Ashwani Gujral

    Buy HDFC Bank, Natco Pharma, Hindalco Industries, Axis Bank; sell TCS: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com is of the view that one can buy HDFC Bank, Natco Pharma, Hindalco Industries and Axis Bank and can sell TCS.

  • Bull's Eye: Buy Thermax, LT Foods, JK Paper, Pfizer, Natco Pharma, GHCL

    Bull's Eye: Buy Thermax, LT Foods, JK Paper, Pfizer, Natco Pharma, GHCL

    Ruchit Jain of Angel Broking is of the view that one may buy NIIT Technologies with a target of Rs 681.

  • Buy Natco Pharma, Jubilant Life; sell IRB Infrastructure, Tata Steel, Voltas: Ashwani Gujral

    Buy Natco Pharma, Jubilant Life; sell IRB Infrastructure, Tata Steel, Voltas: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com is of the view that one can buy Natco Pharma and Jubilant Life Sciences and sell IRB Infrastructure, Tata Steel and Voltas.

  • Stay invested in Natco Pharma: Ashwani Gujral

    Stay invested in Natco Pharma: Ashwani Gujral

    According to Ashwani Gujral of ashwanigujral.com, one may stay invested in Natco Pharma.

  • Buy Natco Pharma, Aurobindo Pharma, Ajanta Pharma: Ashwani Gujral

    Buy Natco Pharma, Aurobindo Pharma, Ajanta Pharma: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com recommends buying Natco Pharma, Aurobindo Pharma and Ajanta Pharma.

  • Lupin may test Rs 1600, says Gaurang Shah

    Lupin may test Rs 1600, says Gaurang Shah

    Gaurang Shah of Geojit Financial Services feels that Lupin may test Rs 1600.

  • Jaiprakash Associates may test Rs 24-25: Ashwani Gujral

    Jaiprakash Associates may test Rs 24-25: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com feels that Jaiprakash Associates may test Rs 24-25.

  • Launch of Copaxone 20 mg can add Rs 8-10 to FY19 EPS for Natco: HDFC Securities

    Launch of Copaxone 20 mg can add Rs 8-10 to FY19 EPS for Natco: HDFC Securities

    Natco Pharma rallies in trade as Mylan gets US Food and Drug Administration (US FDA) nod for Copaxone. In an interview to CNBC-TV18, Amey Chalke, Research Analyst at HDFC Securities spoke about the impact and his strategy on the stock.

  • Accumulate rating on Natco, target price of Rs 940: Nirmal Bang

    Accumulate rating on Natco, target price of Rs 940: Nirmal Bang

    Mylan, distribution partner for Natco Pharma in the US market, gets US Food and Drug Administration (US FDA) nod for generic version of Copaxone 20 mg tablet and 40 mg tablet.

  • Here are a few stock ideas from SP Tulsian

    Here are a few stock ideas from SP Tulsian

    In an interview to CNBC-TV18, SP Tulsian of sptulsian.com shared his readings and outlook on specific stocks and sectors.

  • Buy Avanti Feeds, TV Today, GAIL India, KRBL, Hindustan Zinc: Ashwani Gujral

    Buy Avanti Feeds, TV Today, GAIL India, KRBL, Hindustan Zinc: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com recommends buying Avanti Feeds, TV Today, GAIL India, KRBL and Hindustan Zinc.

  • Buy, Sell, Hold: 2 stocks and 3 sector are being tracked by investors today

    Buy, Sell, Hold: 2 stocks and 3 sector are being tracked by investors today

    ICICI Pru, Natco and OMCs, among others, are on the radar of analysts on Wednesday.

  • Buy Repco Home Finance, Arvind: Sandeep Wagle

    Buy Repco Home Finance, Arvind: Sandeep Wagle

    Sandeep Wagle of powermywealth.com recommends buying Repco Home Finance and Arvind.

  • Buy Aurobindo Pharma, Natco Pharma, Glenmark Pharma: Sudip Bandopadhyay

    Buy Aurobindo Pharma, Natco Pharma, Glenmark Pharma: Sudip Bandopadhyay

    Sudip Bandopadhyay, Market Expert recommends buuying Aurobindo Pharma, Natco Pharma and Glenmark Pharma and expects more than 20 percent upside in one year.

  • Buy Aurobindo Pharma; like Glenmark Pharma, Natco Pharma: Sudip Bandhopadhyay

    Buy Aurobindo Pharma; like Glenmark Pharma, Natco Pharma: Sudip Bandhopadhyay

    Sudip Bandhopadhyay, Market Expert is of the view that one can buy Aurobindo Pharma and likes Glenmark Pharma as well as Natco Pharma..

  • Buy Natco Pharma, Canara Bank, Indiabulls Housing Finance: Ashwani Gujral

    Buy Natco Pharma, Canara Bank, Indiabulls Housing Finance: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com recommends buying Natco Pharma, Canara Bank and Indiabulls Housing Finance.

  • Indian pharma companies should increase base of sales in next few years: Nirmal Bang

    Indian pharma companies should increase base of sales in next few years: Nirmal Bang

    Formulations plant of Dr Reddy's Laboratories at Srikakulam gets inspected and gets 1 observation from United States Foods and Drug Authority (US-FDA). The plant was inspected with zero observations last time.

  • Buy Mahanagar Gas, Natco Pharma, Raymond; prefer Escorts over M&M: Ashwani Gujral

    Buy Mahanagar Gas, Natco Pharma, Raymond; prefer Escorts over M&M: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com suggests buying Mahanagar Gas, Natco Pharma and Raymond and prefers Escorts over M&M.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347